Biohaven Pharmaceutical H...
36.72
1.15 (3.23%)
At close: Jan 15, 2025, 11:18 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY17
Revenue n/a n/a 462.51M n/a n/a n/a
Cost of Revenue 3.37M 1.39M 91.66M 72.00K n/a n/a
Gross Profit -3.37M -1.39M 370.85M -72.00K n/a n/a
Operating Income -436.05M -567.93M -218.90M -114.51M -479.12M n/a
Interest Income 17.73M n/a n/a n/a n/a n/a
Pretax Income -409.55M -569.84M -212.43M -118.67M -528.39M n/a
Net Income -408.17M -570.28M -213.80M -118.67M -528.80M n/a
Selling & General & Admin 62.77M 130.86M 37.41M 16.05M 134.45M n/a
Research & Development 373.28M 437.07M 181.49M 98.46M 344.67M n/a
Other Expenses n/a -1.91M 1.21M n/a n/a n/a
Operating Expenses 436.05M 567.93M 218.90M 114.51M 479.12M n/a
Interest Expense n/a n/a n/a n/a -12.71M n/a
Selling & Marketing Expenses 5.87M n/a n/a n/a n/a n/a
Cost & Expenses 436.05M 567.93M 218.90M 114.51M 479.12M n/a
Income Tax -1.38M 438.00K 1.37M -134.30K 419.00K n/a
Shares Outstanding (Basic) 71.20M 44.74M 35.82M 35.82M 48.49M n/a
Shares Outstanding (Diluted) 71.20M 44.74M 35.82M 35.82M 48.49M n/a
EPS (Basic) -5.73 -12.75 -5.97 -3.31 -10.91 n/a
EPS (Diluted) -5.73 -12.75 -5.97 -3.31 -10.91 n/a
EBITDA -429.14M -462.80M -217.51M -114.43M -479.12M n/a
Depreciation & Amortization 6.91M 1.39M 1.39M 72.00K 171.86K 52.52K

Create Price Alert on BHVN

Your price alert will notify you when the stock price is above 36.72.

Add to Watchlist